ARTICLE | Financial News
Cubist down on Cidecin news
January 17, 2002 8:00 AM UTC
CBST was off $14.73 (46%) to $17.02 on 12.4 million shares on Thursday. On Wednesday after market close, CBST said its Cidecin daptomycin did not meet the primary endpoint of non-inferiority in the re...